In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application

Current Drug Delivery

Volumn 11, Issue 1, 2014, Pages 132-138

  Dasgupta, Sandipan ^a,b   Ghosh, Surajit K ^b   Ray, Subhabrata ^c   Kaurav, Surendra Singh ^d   Mazumder, Bhaskar ^b  

^a NSHM Business School   (India)

^b DIBRUGARH UNIVERSITY   (India)

^c Bengal School of Technology   (India)

^d CIPLA LTD   (India)

Author keywords

Lornoxicam; Nanoemulsion; Surfactant and cosurfactants

Indexed keywords

LORNOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; OIL; OLEIC ACID; OLEIC ACID ETHYL ESTER; POLOXAMER; POLYSORBATE 80; TRIACETIN;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; EMULSION; GEL; IN VITRO STUDY; IN VIVO STUDY; NANOEMULSION; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; REFRACTION INDEX; SKIN PERMEABILITY; STEADY STATE; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DISEASE MODELS, ANIMAL; EDEMA; EMULSIONS; FREUND'S ADJUVANT; GELS; INFLAMMATION; MICROSCOPY, ELECTRON, TRANSMISSION; NANOMEDICINE; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; PIROXICAM; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SOLUBILITY; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; VISCOSITY;

EID: 84894040228     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/15672018113106660063     Document Type: Article

References (25)

1. Cordero, J.A., Alarcon, E., Escribano, R., Obach, J., Domenech, A. A comparative study of the transdermal penetration of a series of NSAIDs. J. Pharm. Sci., 1997, 86, 503-508.
2. Gwak, H.S., Chun, I.K. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm. 2002, 236, 57-64.
3. Yener, G., Gönüllü, Ü, Üner, M., Deim, T., Araman, A. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin. Pharmazie, 2003, 58, 330-333.
4. O'Hanlon, J.J., Mc Cleane, G., Muldoon, T. Preoperative application of piroxicam gel compared to a local anaesthetic field block for postoperative analgesia. Acta Anaesthesiol. Scand., 1996, 40, 715-718.
5. Wilgus, T.A., Ross, M.S., Parrett, M.L., Oberyszy, T.M. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins Other Lipid Mediat., 2000, 62, 367-370.
6. Alvarez-Roman, R., Naik, A., Kalia, Y.N., Guy, R.H., Fessi, H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res., 2004, 21, 1818-1824.
7. Jenning, V., Schafer-Korting, M., Gohla, S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Rel. 2000, 66, 115-126.
8. Alper, O., Yildiz, Ö., and Sevgi, G. Novel Formulation Approaches for Dermal and Transdermal Delivery of Non-Steroidal Anti- Inflammatory Drugs, Rheumatoid Arthritis- Treatment DOI: 10.5772/2303, 2012, 25-48.
9. Azeem, A., Rizwan, M., Ahmad, F.J., Iqbal, Z., Khar, R.K., Aqil, M., Talegaonkar, S. Nanoemulsion components screening and selection: a technical note. AAPS Pharm. Sci. Tech., 2009, 10 (1), 69-76.
10. Craig, D.Q.M., Barker, S.A., Banning, D., Booth, S.W. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int. J. Pharm., 1995, 114, 103-110.
11. Hussaini, S.S.Q., Wang, S., Salihima, T., Sanjay, K.S., and Liu, X. Nanoemulsions of Cancer Chemopreventive Agent Benzyl Isothiocyanate Display Enhanced Solubility, Dissolution, and Permeability. J. Agric. Food Chem., 2011, 59, 12396-12404.
12. Carter, S.J. Dispensing for pharmaceutical students. 12 ed. 2000,p 120.
13. Shafiq-un-Nabi, S., Shakeel, F., Talegaonkar, S. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm., 2007, 66, 227-243
14. Malai, K.D., Narahari, N.P. Sorbitan ester niosomes for topical delivery of rofecoxib. Indian J. Exp. Biol., 2011, 49, 438-445.
15. Marta, P.A., Ana, L.S., Marcos, S., Adriana, R.P., Silvia, S.G. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int. J. Pharm., 2007, 341, 215-220.
16. Das, M.K., Ahmed, A.B. Formulation and ex vivo evaluation of rofecoxib gel for topical application. Acta Pol. Pharm., 2007, 64, 461.
17. Edwards, D.A., and Langer, R. A linear theory of transdermal transport phenomena. J. Pharm. Sci., 1994, 83, 1315-1334.
18. Waitzberg, D. L.; Torrinhas, R. S.; Jacintho, T. M. New parenteral lipid emulsions for clinical use. JPEN, 2006, 30 (4), 351-367.
19. Krohn, K., Koletzko, B. Parenteral lipid emulsions in paediatrics. Curr. Opin. Clin. Nutr. Metab. Care, 2006, 9 (3), 319-323.
20. Hippalgaonkar, K., Majumdar, S., Kansara, V. Injectable lipid emulsions - advancements, opportunities and challenges. AAPS Pharm. Sci. Tech., 2010, 11(4), 1526-1540.
21. Dahan, A., Hoffman, A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J. Control. Release, 2008, 129(1), 1-10.
22. Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., Masuda, K. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. J. Control Release, 2002, 81(1-2), 65-74.
23. Kumar, M., Pathak, K., Misra, A. Formulation and characterization of nanoemulsion-based drug delivery system of risperidone. Drug Dev. Ind. Pharm., 2009, 35 (4), 387-395.
24. Lawrence, M.J., Rees, G.D. Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev., 2000, 45, 89-121.
25. Sanjula, B., Shakeel, F., Alka, A., Javed, A., Sheikh, S. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm., 2007, 57, 315-332.